| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d595ec481a2a081fed4aa2fd4ff52d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15b88775138ca1042b4ef7d7c6a5a19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77d830227bf517c7445084fe1209881b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae3af13cf8aaf48a2b968949a6ba717c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f2c29abde47085e41d2635215413c86 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2005-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e735ba39836975d5e3cf1630386cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c220bbcb31979b7fbcdd260ef1a1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec1ce87df3490cb67646307fa9c4eeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98351b6e21a904f68d7e48a4765699fa |
| publicationDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005113815-A2 |
| titleOfInvention |
Polymorphisms in the fcgr2b promoter and uses thereof |
| abstract |
The invention relates to the FCGR2B gene and its promoter. In particular, the invention relates to FCGR2B promoters with specific nucleotides at polymorphic sites. Characterization of the nucleotides at polymorphic sites is useful for characterizing the gene and the protein and is useful for determining predisposition or susceptibility to certain diseases and infections in a subject or a population of subjects. Such characterization of the gene or protein is also useful for determining immunoresponsiveness or responsiveness to therapeutic agents in a subject or population of subjects. Thus, disclosed herein are a variety of related nucleic acids, methods and tools. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007073179-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062051-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062081-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062081-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062083-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062083-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009062051-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012168300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7994300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103597096-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013186352-A1 |
| priorityDate |
2004-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |